AqueSys, Inc. - Recruiting 45 years or older. - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma.
Aerie Pharmaceuticals - Recruiting 18 years or older. - A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution, 0.01% and PG324 Ophthalmic Solution, 0.02%, Compared to AR-13324 Ophthalmic Solution, 0.02% and Latanoprost Ophthalmic Solution, 0.005% in Patients With Elevated Intraocular Pressure.
Quark Pharmaceuticals - Recruiting 40 years or older. - Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG).
Mati Therapeutics Inc. - Recruiting 18 years or older. - A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma.
Latanoprost Punctal Plug Delivery System (L-PPDS); Timolol Maleate GFS, 0.5%
Alcon Research - Recruiting 18 years or older. - Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTravr in Patients Previously Uncontrolled on a Beta-blocker.
Sensimed AG - Recruiting 18 years or older. - A Single-center, Open Label, Prospective Study Assessing the 24-hour IOP Patterns Using SENSIMED Triggerfishr in Ocular Hypertensive Patients Newly Converted to Glaucomatous Disease Versus Stable Ocular Hypertensive Patients.
University of Colorado, Denver - Recruiting 18 years or older. - A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells..
Vasan Eye Care Hospital - Recruiting 18 years to 75 years. - A Cross Sectional Study of Correlation Between Retinal Nerve Fibre Thickness Measured by Optical Coherence Tomography and Humphrey Visual Fields in Early and Moderate Open Angle Glaucoma.
Glaukos Corporation - Recruiting 18 years or older. - A Prospective Evaluation of Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin.
Glaukos Corporation - Recruiting 45 years or older. - A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukosr Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery.
Alcon Research - Recruiting 18 years or older. - Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination Therapy.
Oftalmologia Hospital Sotero del Rio - Recruiting 18 years or older. - Effect of Exposure to Computer Simulated Visual Field Testing on Variability and Reliability of Test Results: A Randomized Controlled Trial.